This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Cochlear
Cochlear Limited, commonly referred to as Cochlear, is a global leader in implantable hearing solutions, headquartered in Sydney, Australia. Founded in 1981, the company has pioneered advancements in the field of audiology, particularly with its innovative cochlear implants and bone conduction devices. Cochlear operates in key markets across Europe, North America, and Asia, providing life-changing hearing solutions to individuals with hearing loss. Its flagship products, including the Nucleus® cochlear implant system and the Baha® bone conduction system, are distinguished by their cutting-edge technology and commitment to improving user experience. With a strong market position, Cochlear has received numerous accolades for its contributions to hearing health, solidifying its reputation as a trusted name in the industry. The company continues to lead the way in research and development, ensuring that it remains at the forefront of hearing innovation.
DitchCarbon Score
How does Cochlear's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Furniture Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cochlear's score of 48 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cochlear's reported carbon emissions
In 2024, Cochlear Limited reported total carbon emissions of approximately 6,036,000 kg CO2e, with Scope 1 emissions at about 856,000 kg CO2e, Scope 2 emissions at approximately 2,183,000 kg CO2e, and Scope 3 emissions reaching about 2,997,000 kg CO2e, which includes significant business travel emissions of approximately 14,418,000 kg CO2e. This marks a slight decrease from 2023, where total emissions were about 6,326,000 kg CO2e. Cochlear has set ambitious climate commitments, aiming for a 25% reduction in absolute Scope 1 and Scope 2 emissions by 2025, based on a 2019 baseline. Additionally, the company targets net-zero emissions in its operations (Scope 1 and 2) by 2030. For Scope 3 emissions, Cochlear aims for a 50% reduction in business flight-related emissions by FY25. The company’s emissions data is independently reported and does not cascade from any parent organization. Cochlear's commitment to sustainability reflects its proactive approach to addressing climate change within the medical technology industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 728,000 | 000,000 | 000,000 | 000,000 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 13,537,000 | 0,000,000 | 0,000,000 | 00,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | 00,000,000 | 0,000,000 | 000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cochlear is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
